Term
|
Definition
Thymus derived cells that have receptors that are activated by binding with foreign antigens
Secrete mediators that influence the response of other cell types involved in the recognition and destruction of foreign substances |
|
|
Term
|
Definition
Differentiate into specific plasma cells that synthesize antibodies
aka bursa derived cells |
|
|
Term
|
Definition
"GAMED"
IgG
IgA
IgM
IgE
IgD |
|
|
Term
|
Definition
Cause the release of histamine and other chemicals that cause allergic reactions
Main player in anaphylaxis |
|
|
Term
|
Definition
Monocytes and Macrophages
Neutrophils (aka polymorphic leukocytes)
Eosinophils
Mast Cells (histamine releasing) |
|
|
Term
|
Definition
Inflammatory cell activators synthesized by macrophages to act as secondary messengers and activate endothelial cells and WBCs
Interleukin causes histamine release and bronchospasm |
|
|
Term
|
Definition
System of 20 differnt proteins that bind to activated antibodies, cell membranes, and other complement proteins
Primary humoral response |
|
|
Term
Effects of Anesthesia on Immune System |
|
Definition
DEPRESSES nonspecific host resistance
Affected by anesthetic drugs, other effects of drugs used in surgery, surgery itself, coincident infections, and blood products |
|
|
Term
|
Definition
Anaphylactic or Immediate reaction (minutes to an hour post exposure)
Caused by antigen bining to IgE antibodies (mast cells released mediators-histamine)
Need to have PREVIOUS exposure to antigen
Symptoms can last up to 36 hrs |
|
|
Term
|
Definition
Anaphylaxis
Extrinsic Asthma
Urticaria (hives)
Allergic Rhinitis
Angioedema (especially laryngeal)
HOTN
Wheezing/Bronchospasm
Arryhtmias |
|
|
Term
|
Definition
Non-IgE-mediated reaction caused by histamine release from basophils and mast cells
symptoms usually less severe |
|
|
Term
|
Definition
"Cytotoxic"
Antibody-dependent cell-mediated cytotoxic hypersensitivity
IgG and IgM
Cell damage: direct lysis, increased phagocytosis, killer-T cells produce cytotoxic effects
Ex. ABO incompatible tranfusions reactions, drug induced hemolytic anemia, HIT |
|
|
Term
|
Definition
" Immune Complex"
Antigen/Antibody complexes deposit in microvasculature
Complement is activated and neutrophils are localized to site of complement deposition which produces tissue damage
Ex. serum sickness, snake antisera, protamine mediated pulmonary vasoconstriction |
|
|
Term
|
Definition
"Delayed"
Results from interactions of sensitized lymphocytes with specific antigens= delayed hypersensitivity
Manifests 18-24 hrs and disapppears 72-96 hrs later
Ex. Contact dermatitis, tissue rejection, GVHD |
|
|
Term
Respiratory Signs of Anaphylaxis |
|
Definition
Coughing
Wheezing
Laryngeal edema
Decreased pulmonary compliance
Pulmonary Edema
Respiratory Failure |
|
|
Term
Cardiovascular Signs of Anaphylaxis |
|
Definition
Disorientation
Diaphoresis
LOC changes
HOTN
Tachycardia
Dysrhythmias
Decreased SVR
CV arrest
Pulmonary HTN |
|
|
Term
Cutaneous Signs of Anaphylaxis |
|
Definition
Urticaria (hives)
Flushing
Periorbital edema
Perioral edema |
|
|
Term
|
Definition
Releases endothelium derived releasing factors- NO
Increases capillary permeability
Constricts airway and vascular smooth muscle |
|
|
Term
|
Definition
Causes gastric secretion
Inhibits mast cell activation
Contributes to vasodilation |
|
|
Term
|
Definition
Peptide Mediators
Arachidonic Metabolities
Kinins
Platlet Aggregating Factors |
|
|
Term
|
Definition
Released from mast cells and basophils that cause chemotaxis and collection at the site of inflammation |
|
|
Term
|
Definition
Leukotrienes and Prostaglandins are both synthesized after mast cell activation from arachidonic acid metabolism of phospholipid membrane |
|
|
Term
|
Definition
Synthesized in mast cells and basophils to produce vasodilation, increased capillary permeability, and bronchoconstriction
Can stimulate vascular endothelium to release prostacyclin and NO |
|
|
Term
Platlet Aggregating Factor |
|
Definition
Aggregates and activates human platlets to release inflammatory products |
|
|
Term
Non-IgE Mediated Response |
|
Definition
Complement Activation- release biologicall active complement fragments of C3 and C5
C3 and C5 release histmaine from mast cells and basophils, contract smooth muscle, increase capillary permeability, and cause interleukin synthesis (bronchoconstriction)
It is a non-immunologic release of histamine |
|
|
Term
Antihistamine Pretreatment |
|
Definition
Drug competes with histamine at receptor sites
Do NOT prevent the release...just keep it from binding
H1 and H2 need to block both |
|
|
Term
Drugs that Cause NonImmunologic Histamine Release |
|
Definition
Antibiotics (vanc)
Basic Compounds
Muscle Relaxants (NMB)
Opioids (Morphine and Demerol)
Thioibarbiturates |
|
|
Term
|
Definition
Leukocytes Histamine Release
Radioallergosorbent Test (RAST)
Enzyme-Linked Immunosorbent Assay (ELISA)
Intradermal Testing (Skin Testing) |
|
|
Term
Agents Most Likely To Trigger Reactions |
|
Definition
NMBs
Latex
Antibiotics
Other (contrast, protamine, etc.)
Colloids
Opioids
Hypnotics
LA |
|
|
Term
|
Definition
Contain perservatives, accelerators, antioxidants
Healthcare workers, spina bifida, GU abnormalities
Bananas, Avocado, Kiwi |
|
|
Term
|
Definition
Divalent- capable of cross linking cell surface IgE and causing mediator release from mast cells and basophils without binding to larger carrier molecule |
|
|
Term
|
Definition
Airway Maintenance
100% O2
IV Volume Expansion
Epinephrine
Stops all anesthetic drugs- treat hypoxia and hypotension |
|
|
Term
Volume Expansion During Anaphylaxis |
|
Definition
40% loss due to 3rd spacing
2-4 L LR (adults)
25-50 ml/kg cyrstalloids- additional benefit |
|
|
Term
Epinephrine in Anaphylaxis |
|
Definition
CV Unstable: 5-10 mcg IV bolus, 0.1-1 mg infusion with CV collapse
CV Stable: 0.1-0.5 mg SC/IM |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
B-agonists
Albuterol, Terbutaline, Ipratropium |
|
|
Term
Hydrocortisone
(Solucortef) |
|
Definition
|
|
Term
Methylprednisone
(Solumedrol) |
|
Definition
|
|
Term
|
Definition
0.5-1 mEq/kg
May repeat q 5 min
Acidosis reduces effect of epi |
|
|
Term
Refractory HOTN in Anaphylaxis |
|
Definition
Vasopressin: gtt @ 0.01 units/min |
|
|